Musculoskeletal disorders include rheumatoid arthritis, osteoarthritis, sarcopenia, injury, stiffness, and bone loss. The prevalence of these conditions is frequent among elderly populations with significant mobility and mortality rates. This may lead to extreme discomfort and detrimental effect on the patient’s health and socioeconomic situation. Muscles, ligaments, tendons, and soft tissue are vital for body function and movement. Matrix metalloproteinases (MMPs) are regulatory proteases involved in synthesizing, degrading, and remodeling extracellular matrix (ECM) components. By modulating ECM reconstruction, cellular migration, and differentiation, MMPs preserve myofiber integrity and homeostasis. In this review, the role of MMPs in skeletal muscle function, muscle injury and repair, skeletal muscle inflammation, and muscular dystrophy and future approaches for MMP-based therapies in musculoskeletal disorders are discussed at the cellular and molecule level.

Chronic obstructive pulmonary disease (COPD) is pulmonary emphysema characterized by blockage in the airflow resulting in the long‐term breathing problem, hence a major cause of mortality worldwide. Excessive generation of free radicals and the development of chronic inflammation are the major two episodes underlying the pathogenesis of COPD. Currently used drugs targeting these episodes including anti‐inflammatory, antioxidants, and corticosteroids are unsafe, require high doses, and pose serious side effects. Nanomaterial‐conjugated drugs have shown promising therapeutic potential against different respiratory diseases as they are required in small quantities which lower overall treatment costs and can be effectively targeted to diseased tissue microenvironment hence having minimal side effects. Poly lactic‐co‐glycolic acid (PLGA) nanoparticles (NPs) are safe as their breakdown products are easily metabolized in the body. Drugs loaded on the PLGA NPs have been shown to be promising agents as anticancer, antimicrobial, antioxidants, and anti‐inflammatory. Surface modification of PLGA NPs can further improve their mechanical properties, drug loading potential, and pharmacological activities. In the present review, we have presented a brief insight into the pathophysiological mechanism underlying COPD and highlighted the role, potential, and current status of PLGA NPs loaded with drugs in the therapy of COPD.

Anaerobic ammonium oxidation (anammox) technologies have attracted substantial interest due to their advantages over traditional biological nitrogen removal processes, including high efficiency and low energy demand. Currently, multiple side-stream applications of the anammox coupling process have been developed, including one-stage, two-stage, and three-stage systems such as completely autotrophic nitrogen removal over nitrite, denitrifying ammonium oxidation, simultaneous nitrogen and phosphorus removal, partial denitrification-anammox, and partial nitrification and integrated fermentation denitritation. The one-stage system includes completely autotrophic nitrogen removal over nitrite, oxygen-limited autotrophic nitrification/denitrification, aerobic de-ammonification, single-stage nitrogen removal using anammox, and partial nitritation. Two-stage systems, such as the single reactor system for high-activity ammonium removal over nitrite, integrated fixed-film activated sludge, and simultaneous nitrogen and phosphorus removal, have also been developed. Three-stage systems comprise partial nitrification anammox, partial denitrification anammox, simultaneous ammonium oxidation denitrification, and partial nitrification and integrated fermentation denitritation. The performance of these systems is highly dependent on interactions between functional microbial communities, physiochemical parameters, and environmental factors. Mainstream applications are not well developed and require further research and development. Mainstream applications demand a high carbon/nitrogen ratio to maintain levels of nitrite-oxidizing bacteria, high concentrations of ammonium and nitrite in wastewater, and retention of anammox bacteria biomass. To summarize various aspects of the anammox processes, this review provides information regarding the microbial diversity of different genera of anammox bacteria and the engineering aspects of various side streams and mainstream anammox processes for wastewater treatment. Additionally, this review offers detailed insights into the challenges related to anammox technology and delivers solutions for future sustainable research.